ask="4.82"
ask_size="300"
average_daily_volume="692852"
bid="4.58"
bid_size="600"
book_value="5.03"
change="+0.39"
change_from_200_day_moving_average="1.56"
change_from_50_day_moving_average="1.61"
change_from_52_week_high="-14.62"
change_From_52_week_low="2.93"
change_in_percent="+9.31%"
close="4.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.44"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-5.02"
ex_dividend_date="N/A"
float_shares="9594000"
high="4.65"
high_52_weeks="19.20"
last_trade_date="2/7/2017"
last_trade_price="4.58"
last_trade_size="15805"
last_trade_time="4:00pm"
low="4.12"
low_52_weeks="1.65"
market_capitalization="66.80M"
moving_average_200_day="3.02"
moving_average_50_day="2.97"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="11.67"
open="4.19"
pe_ratio="N/A"
peg_ratio="0.01"
percent_change_from_200_day_moving_average="+51.50%"
percent_change_from_50_day_moving_average="+54.10%"
percent_change_from_52_week_high="-76.15%"
percent_change_from_52_week_low="+177.58%"
previous_close="4.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.83"
price_per_sales="2.47"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="2.18"
stock_exchange="NMS"
symbol="OREX"
volume="807558"
weeks_range_52="1.65 - 19.20"
